These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23499052)

  • 1. Type I to type II ovarian carcinoma progression: mutant Trp53 or Pik3ca confers a more aggressive tumor phenotype in a mouse model of ovarian cancer.
    Wu R; Baker SJ; Hu TC; Norman KM; Fearon ER; Cho KR
    Am J Pathol; 2013 Apr; 182(4):1391-9. PubMed ID: 23499052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of TRP53, PTEN, RB1, and/or CDH1 in the ovarian surface epithelium induces ovarian cancer transformation and metastasis.
    Shi M; Whorton AE; Sekulovski N; Paquet M; MacLean JA; Song Y; Van Dyke T; Hayashi K
    Biol Reprod; 2020 Apr; 102(5):1055-1064. PubMed ID: 31930396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIK3CA alterations in Middle Eastern ovarian cancers.
    Abubaker J; Bavi P; Al-Haqawi W; Jehan Z; Munkarah A; Uddin S; Al-Kuraya KS
    Mol Cancer; 2009 Jul; 8():51. PubMed ID: 19638206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice.
    Kinross KM; Montgomery KG; Kleinschmidt M; Waring P; Ivetac I; Tikoo A; Saad M; Hare L; Roh V; Mantamadiotis T; Sheppard KE; Ryland GL; Campbell IG; Gorringe KL; Christensen JG; Cullinane C; Hicks RJ; Pearson RB; Johnstone RW; McArthur GA; Phillips WA
    J Clin Invest; 2012 Feb; 122(2):553-7. PubMed ID: 22214849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated mutant p110α causes endometrial carcinoma in the setting of biallelic Pten deletion.
    Joshi A; Miller C; Baker SJ; Ellenson LH
    Am J Pathol; 2015 Apr; 185(4):1104-13. PubMed ID: 25698082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways.
    Wu R; Hendrix-Lucas N; Kuick R; Zhai Y; Schwartz DR; Akyol A; Hanash S; Misek DE; Katabuchi H; Williams BO; Fearon ER; Cho KR
    Cancer Cell; 2007 Apr; 11(4):321-33. PubMed ID: 17418409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial ovarian cancer: rationale for changing the one-fits-all standard treatment regimen to subtype-specific treatment.
    Despierre E; Yesilyurt BT; Lambrechts S; Johnson N; Verheijen R; van der Burg M; Casado A; Rustin G; Berns E; Leunen K; Amant F; Moerman P; Lambrechts D; Vergote I;
    Int J Gynecol Cancer; 2014 Mar; 24(3):468-77. PubMed ID: 24557434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo.
    Mullany LK; Fan HY; Liu Z; White LD; Marshall A; Gunaratne P; Anderson ML; Creighton CJ; Xin L; Deavers M; Wong KK; Richards JS
    Oncogene; 2011 Aug; 30(32):3522-36. PubMed ID: 21423204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian clear cell carcinoma.
    Abe A; Minaguchi T; Ochi H; Onuki M; Okada S; Matsumoto K; Satoh T; Oki A; Yoshikawa H
    Hum Pathol; 2013 Feb; 44(2):199-207. PubMed ID: 22955107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternate molecular genetic pathways in ovarian carcinomas of common histological types.
    Willner J; Wurz K; Allison KH; Galic V; Garcia RL; Goff BA; Swisher EM
    Hum Pathol; 2007 Apr; 38(4):607-13. PubMed ID: 17258789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant p53 Promotes Epithelial Ovarian Cancer by Regulating Tumor Differentiation, Metastasis, and Responsiveness to Steroid Hormones.
    Ren YA; Mullany LK; Liu Z; Herron AJ; Wong KK; Richards JS
    Cancer Res; 2016 Apr; 76(8):2206-18. PubMed ID: 26964623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective gene expression profiling of mTOR-associated tumor suppressor and oncogenes in ovarian cancer.
    Laudański P; Kowalczuk O; Klasa-Mazurkiewicz D; Milczek T; Rysak-Luberowicz D; Garbowicz M; Baranowski W; Charkiewicz R; Szamatowicz J; Chyczewski L
    Folia Histochem Cytobiol; 2011; 49(2):317-24. PubMed ID: 21744334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arid1a inactivation in an Apc- and Pten-defective mouse ovarian cancer model enhances epithelial differentiation and prolongs survival.
    Zhai Y; Kuick R; Tipton C; Wu R; Sessine M; Wang Z; Baker SJ; Fearon ER; Cho KR
    J Pathol; 2016 Jan; 238(1):21-30. PubMed ID: 26279473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of p53-dependent growth suppression in human cells by mutations in PTEN or PIK3CA.
    Kim JS; Lee C; Bonifant CL; Ressom H; Waldman T
    Mol Cell Biol; 2007 Jan; 27(2):662-77. PubMed ID: 17060456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trp53 null and R270H mutant alleles have comparable effects in regulating invasion, metastasis, and gene expression in mouse colon tumorigenesis.
    Tang J; Feng Y; Kuick R; Green M; Green M; Sakamoto N; Kurosu Y; Lin J; Cho KR; Fearon ER
    Lab Invest; 2019 Oct; 99(10):1454-1469. PubMed ID: 31148594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for
    Al-Qahtani WS; Alduwish MA; Al-Olayan EM; Aljarba NH; Em AH; Albani FG; Domiaty DM; Al-Otaibi AM; Qattan SMA; Almurshedi AS; Elasbali AM; Ahmed HG; Almutlaq BA
    J Obstet Gynaecol; 2021 Oct; 41(7):1127-1133. PubMed ID: 33475035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.
    Kurman RJ; Shih IeM
    Hum Pathol; 2011 Jul; 42(7):918-31. PubMed ID: 21683865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of oviductal versus ovarian epithelial cell of origin on ovarian endometrioid carcinoma phenotype in the mouse.
    Wu R; Zhai Y; Kuick R; Karnezis AN; Garcia P; Naseem A; Hu TC; Fearon ER; Cho KR
    J Pathol; 2016 Nov; 240(3):341-351. PubMed ID: 27538791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian target of rapamycin is a therapeutic target for murine ovarian endometrioid adenocarcinomas with dysregulated Wnt/β-catenin and PTEN.
    Tanwar PS; Zhang L; Kaneko-Tarui T; Curley MD; Taketo MM; Rani P; Roberts DJ; Teixeira JM
    PLoS One; 2011; 6(6):e20715. PubMed ID: 21695255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a New Ovarian Cancer Cell Line CA5171.
    Chiang YC; Cheng WF; Chang MC; Lu TP; Kuo KT; Lin HP; Hsieh CY; Chen CA
    Reprod Sci; 2015 Jun; 22(6):725-34. PubMed ID: 25394645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.